Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beate Sander

Showing results (111-120 of 205) with videos related to

Pageof 21
Sort By:
Plos One|October 6, 2025
Effect of sustained virologic response on liver-related mortality among individuals living with hepatitis C by treatment era: A population-based retrospective cohort studyAysegul Erman, Karl Everett, William W L Wong, et al.
Hepatology Communications|August 9, 2023
Engagement with the HCV care cascade among high-risk groups: A population-based studyAysegul Erman, Karl Everett, William W L Wong, et al.
Plos Currents|January 1, 2010
Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Early Evidence from the Canadian ExperienceBeate Sander, Chris Bauch, David N Fisman, et al.
Plos One|June 2, 2018
Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014Karen O Johnson, Mark P Nelder, Curtis Russell, et al.
BMJ Open Ophthalmology|March 3, 2022
Diagnostic accuracy of teleretinal screening for detection of diabetic retinopathy and age-related macular degeneration: a systematic review and meta-analysisParsa Mehraban Far, Felicia Tai, Adeteju Ogunbameru, et al.
International Journal of Technology Assessment in Health Care|June 25, 2026
Measuring, Valuing, and Incorporating Patient and Caregiver Productivity Costs in Economic Evaluations: A Scoping Review and Environmental ScanShant Torkom Yeretzian, Carly Sillcox, Hannah Loshak, et al.
Cost Effectiveness and Resource Allocation : C/E|August 31, 2022
Do Health Technology Assessment organisations consider manufacturers' costs in relation to drug price? A study of reimbursement reportsJoost J Enzing, Saskia Knies, Jop Engel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 21, 2020
Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over timeLauren Lapointe-Shaw, Hannah Chung, Beate Sander, et al.
Vaccine|February 20, 2016
The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting - Can we do better?Beate Sander, William W L Wong, Man Wah Yeung, et al.
Annals of Epidemiology|July 27, 2021
A disproportionate epidemic: COVID-19 cases and deaths among essential workers in Toronto, CanadaAmrita Rao, Huiting Ma, Gary Moloney, et al.
Pageof 21

Showing results (111-120 of 205) with videos related to

Sort By:
Pageof 21
Plos One|October 6, 2025
Effect of sustained virologic response on liver-related mortality among individuals living with hepatitis C by treatment era: A population-based retrospective cohort studyAysegul Erman, Karl Everett, William W L Wong, et al.
Hepatology Communications|August 9, 2023
Engagement with the HCV care cascade among high-risk groups: A population-based studyAysegul Erman, Karl Everett, William W L Wong, et al.
Plos Currents|January 1, 2010
Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Early Evidence from the Canadian ExperienceBeate Sander, Chris Bauch, David N Fisman, et al.
Plos One|June 2, 2018
Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014Karen O Johnson, Mark P Nelder, Curtis Russell, et al.
BMJ Open Ophthalmology|March 3, 2022
Diagnostic accuracy of teleretinal screening for detection of diabetic retinopathy and age-related macular degeneration: a systematic review and meta-analysisParsa Mehraban Far, Felicia Tai, Adeteju Ogunbameru, et al.
International Journal of Technology Assessment in Health Care|June 25, 2026
Measuring, Valuing, and Incorporating Patient and Caregiver Productivity Costs in Economic Evaluations: A Scoping Review and Environmental ScanShant Torkom Yeretzian, Carly Sillcox, Hannah Loshak, et al.
Cost Effectiveness and Resource Allocation : C/E|August 31, 2022
Do Health Technology Assessment organisations consider manufacturers' costs in relation to drug price? A study of reimbursement reportsJoost J Enzing, Saskia Knies, Jop Engel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 21, 2020
Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over timeLauren Lapointe-Shaw, Hannah Chung, Beate Sander, et al.
Vaccine|February 20, 2016
The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting - Can we do better?Beate Sander, William W L Wong, Man Wah Yeung, et al.
Annals of Epidemiology|July 27, 2021
A disproportionate epidemic: COVID-19 cases and deaths among essential workers in Toronto, CanadaAmrita Rao, Huiting Ma, Gary Moloney, et al.
Pageof 21